5-Hydroxydecanoate fails to attenuate ventricular fibrillation in a conscious canine model of sudden cardiac death

European Journal of Pharmacology

Volumn 306, Issue 1-3, 1996, Pages 99-106

  Friedrichs, Gregory S ^a   Abreu, Jose Nelson ^a   Black, Shawn C ^a   Chi, Liguo ^a   Lucchesi, Benedict R ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

ATP dependent K+ channel blocker; cardiac arrhythmia; ventricular fibrillation

Indexed keywords

5 HYDROXYDECANOIC ACID; POTASSIUM CHANNEL BLOCKING AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BOLUS INJECTION; CONSCIOUSNESS; CONTINUOUS INFUSION; CONTROLLED STUDY; DOG; HEART ELECTROPHYSIOLOGY; HEART INFARCTION; HEART MUSCLE REFRACTORY PERIOD; HEART PACING; HEART VENTRICLE FIBRILLATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; QT INTERVAL; SUDDEN DEATH;

EID: 0030582093     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00208-7     Document Type: Article

References (24)

1. Auchampach, J.A., G.J. Grover and G.J. Gross, 1992, Blockade of ischemic preconditioning in dogs by the novel ATP-dependent potassium channel antagonist sodium 5-hydroxydecanoate, Cardiovasc. Res. 26, 1054.
2. Black, S.C., L. Chi, D.-X. Mu and B.R. Lucchesi, 1991, The antifibrillatory actions of UK-68,798, a class III antiarrhythmic agent, J. Pharmacol. Exp. Ther. 258, 416.
3. Black, S.C., J.L. Butterfield and B.R. Lucchesi, 1993, Protection against programmed electrical stimulation-induced ventricular tachycardia and sudden cardiac death by NE-10064, a class III antiarrhythmic drug, J. Cardiovasc. Pharmacol. 22, 810.
4. Black, S.C., G.S. Friedrichs and B.R. Lucchesi, 1993. The autonomic nervous system, myocardial infarct size and ventricular fibrillation. J. Mol. Cell. Cardiol. 25. 1291.
5. Billman, G.E., C.E. Avendana, J.R. Halliwill and J.M. Burroughs, 1993, The effect of the ATP-dependent potassium channel antagonist, glyburide, on coronary blood flow and susceptibility to ventricular fibrillation in unanesthetized dogs, J. Cardiovasc. Pharmacol. 21, 197.
6. Chi, L., D.-X. Mu and B.R. Lucchesi, 1991, Electrophysiology and antiarrhythmic actions of E-4031 in the experimental animal model of sudden coronary death, J. Cardiovasc. Pharmacol. 17, 285.
7. Escande D. and P. Henry, 1993, Potassium channels as pharmacological targets in cardiovascular medicine, Eur. Heart J. 14 (suppl.), B2.
8. Friedrichs, G.S., L. Chi, M.R. Gralinski, S.C. Black, G.C. Basler, D.-X. Mu, S.R. Pewitt, C.R. Johnson and B.R. Lucchesi, 1995, MS-551 protects against ventricular fibrillation in a chronic canine model of sudden cardiac death, J. Cardiovasc. Pharm. 25, 314.
9. Haworth, R.A., A.T. Goknur and H.A. Berkoff, 1989, Inhibition of ATP-sensitive potassium channels of adult rat heart cells by antiarrhythmic drugs, Circ. Res. 65, 1157.
10. Legato, M.J., 1993, The anatomic matrix as a factor in susceptibility to lethal arrhythmias in a canine model of sudden cardiac death, J. Mol. Cell. Cardiol. 25, 501.
11. Lynch, J.J., L.A. Coskey, D.G. Montgomery and B.R. Lucchesi, 1985, Prevention of ventricular fibrillation by dextrorotatory sotalol in a conscious canine model of sudden coronary death, Am. Heart J. 109, 949.
12. McCullough, J.R., D.E. Normandin, M.L. Conder, P.G. Sleph, S. Dzwonczyk and G.J. Grover, 1991, Specific block of the anti-ischemic actions of cromakalim by sodium 5-hydroxydecanoate, Circ. Res. 69, 949.
13. Moritani, K., T. Miyazaki, S. Miyoshi, M. Asanagi, L. Zhao, H. Mitamura and S. Ogawa, 1994, Blockade of ATP-sensitive potassium channels by 5-hydroxydecanoate suppresses monophasic action potential shortening during regional myocardial ischemia, Cardiovasc. Drugs Ther. 8, 749.
14. Niho, T., T. Notsu, H. Ishikawa, H. Funato, M. Yamazaki, H. Takahashi, I. Tanaka, M. Kayamoto, T. Dabasaki and F. Yamasaki, 1987, Study of mechanism and effect of sodium 5-hydroxydecanoate on experimental ischemic ventricular arrhythmia, Nippon Yakurigaku Zasshi. 89, 155.
15. + channels in cardiac muscle, Nature, 305(5930), 147.
16. + channel currents in guinea-pig single ventricular myocytes, Eur. J. Pharmacol. 220, 35.
17. + channel by 5-hydroxydecanoate in guinea pig ventricular myocytes, J. Pharmacol. Exp. Ther. 260, 702.
18. Patterson, E., K. Holland, B.T. Eller and B.R. Lucchesi, 1982, Ventricular fibrillation resulting from ischemia at a site remote from previous myocardial infarction. A conscious canine model of sudden coronary death, Am. J. Cardiol. 50, 1414.
19. Pogatsa, G., M.Z. Koltai, I. Balkanyi, I. Devai, V. Kiss and A. Koszneghy, 1988, The effect of various hypoglycemic sulfonylureas on the cardiotoxicity of glycosides and arrhythmogenic activity due to myocardial ischemia, Acta Physiol. Hung. 71, 243.
20. Wilber, D.J., J.J. Lynch and B.R. Lucchesi, 1985, Postinfarction sudden death: Significance of inducible ventricular tachycardia and infarct size in a conscious canine model, Am. Heart J. 109, 8.
21. + and pH during ischemia: Comparison with glibenclamide, Circulation 90, I-466 [abstr].
22. Wollenben C.D., M.C. Sanguinetti and P.K. Siegl, 1989, Influence of ATP-sensitive potassium channel modulators on ischemia-induced fibrillation in isolated rat hearts, J. Mol. Cell. Cardiol. 21, 783.
23. Woosley, R.L., 1991, Antiarrhythmic drugs, Ann. Rev. Pharmacol. Toxicol. 31, 427.
24. Wyatt, C.J., R.L. Pereira and E.A. Day, 1967, The lactone precursor in fresh milk fat: Identification of the hydroxy fatty acids, Lipids 2, 208.